4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001387131-18-005141
Director sold 182,800 shares at an average $6.59 ($1,204,561)
- Director acquired 182,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bernick Brian · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-09-27 | Exercise or conversion : show line 1 in the form | +91,400 | $0.10 | $9,305 | 6,648,771 | I |
| 2018-09-27 | Sale : show line 2 in the form | −91,400 | $6.63 | $605,982 | 6,557,371 | I |
| 2018-09-28 | Exercise or conversion : show line 3 in the form | +91,400 | $0.10 | $9,305 | 6,648,771 | I |
| 2018-09-28 | Sale : show line 4 in the form | −91,400 | $6.55 | $598,579 | 6,557,371 | I |
| Open-market sales · 182,800 sh · avg $6.59 · $1,204,561 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-09-27 | Exercise or conversion : show line 5 in the form Non-Qualified Stock Option (right to buy) | −91,400 | 1,188,710 | I |
| 2018-09-28 | Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) | −91,400 | 1,097,310 | I |
Loading xslF345X03/bernick-form4_092718.xml…